Muhammad Aslam

Muhammad Aslam

Auto-generated profile, based on publicly available information

Muhammad Aslam

Department of Physiology, Army Medical College, Rawalpindi, Pakistan

Research Focus & Metrics

Academic Career Length

40Years (1987-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 August 2004 in Diabetes, Obesity and Metabolism
Verified
Journal Article
Closed access
PDF file
SHSyed Shahid Habib
Syed Shahid Habib
MAM. Aslam
M. Aslam

1 October 2008
Verified
Journal Article
Closed access
RLRabia Latif
Rabia Latif
GLGhulam Mustafa Lodhi
Ghulam Mustafa Lodhi
MAMuhammad Aslam
Muhammad Aslam

1 February 2009
Verified
Journal Article
Closed access
ANAmina Nadeem
Amina Nadeem
MAMuhammad Aslam
Muhammad Aslam
DKDilshad Ahmad Khan
Dilshad Ahmad Khan
THTassawar Hussain
Tassawar Hussain
SKSaadat Ali Khan
Saadat Ali Khan

1 July 2012
Verified
Journal Article
Closed access
WHWaqas Hameed
Waqas Hameed
IYIftekhar Yousaf
Iftekhar Yousaf
RLRabia Latif
Rabia Latif
MAMuhammad Aslam
Muhammad Aslam

1 January 1987 in Neuroendocrinology
Verified
Journal Article
Closed access
PDF file
SNSarah Nicholson
Sarah Nicholson
MAMuhammad Aslam
Muhammad Aslam
BGBrian Gillham
Brian Gillham
MJMortyn Jones
Mortyn Jones
Anterior pituitary gland fragments were obtained from female Wistar-derived rats on dioestrus or pro-oestrus and perifused in Biogel columns in vitro. They were subjected at the beginning of each of 5 h of perifusion to a volley of 6 1-min pulses of luteinising hormone-releasing hormone (LHRH, 10 nM), given 4 min apart. Luteinising hormone (LH) was measured by radioimmunoassay in sequential 2-min fractions of the perifusate. Pituitary glands removed at 14.00 h on dioestrus showed a characteristic pattern of sensitisation followed by desensitisation to the repeated volleys of LHRH, whereas tissues removed at 10.00 or 14.00 h on pro-oestrus showed no evidence of desensitisation over the 5-hour period, the response to each LHRH volley being greater than the preceding one. Estradiol (E, 3–100 pg/ml) added to the medium from the start of perifusion had no significant effect on the pattern of response from tissues removed on pro-oestrus, but the highest concentration significantly enhanced the response of dioestrus pituitaries to all but the last of the LHRH volleys. Progesterone (P, 1–50 ng/ml) added to the medium produced a dose-related inhibition of the response of pro-oes-trous tissues to the LHRH volleys. Groups of animals were ovariectomised (OVX) on dioestrus and used for experiment the next morning. OVX at 10.00 h on dioestrus produced the pattern of response characteristic of dioestrus the next morning, but with much higher levels of LH release, which were unaltered by the addition of E to the medium. OVX at 17.00 h on dioestrus produced an entirely different pattern of response the next day, with high basal and moderate LHRH-induced LH release, and no evidence of changes in sensitivity of the tissue. In this case, E in vitro had a moderate enhancing effect. Various doses of E were injected subcutaneously immediately after OVX at 10.00 h on dioestrus; 1 µg/100 g body weight E had no effect on the subsequent pattern of response (sensitisation followed by desensitisation), but produced significantly greater LH release during the second, third and fourth volleys of LHRH; the pattern of LH release was also unaffected by P alone (2 mg per rat at 17.00 h after OVX), but the output throughout the perifusion was significantly reduced; 10 µg E completely changed the pattern, to one resembling that seen from tissues removed from intact pro-oestrus rats, but basal and LHRH-induced release were still markedly raised. 30 or 100 µg E reduced basal LH release to intact or sham-operated levels, but had no inhibitory effect on the high LHRH-induced release of LH. Both the pattern and magnitude of release were only restored to those exhibited by pituitaries from normal pro-oestrous animals when both 10 µg/100 g E and 2 mg P were given. In conclusion, these results suggest that this preparation is a suitable in vitro model for studying the mechanisms involved in the LH surge. Prolonged sensitisation to repeated LHRH stimulation is characteristic of pro-oestrous pituitaries, whereas dioestrus tissues show desensitisation. The pro-oestrous pattern could be restored in OVX animals by sufficient E replacement for 1 day, the addition of P replacement reducing the output of LH to normal.

1 June 2010
Verified
Journal Article
Open access
ANAmina Nadeem
Amina Nadeem
MHMuhammad Mazhar Hussain
Muhammad Mazhar Hussain
MAMuhammad Aslam
Muhammad Aslam
THTassawar Hussain
Tassawar Hussain
Chronic hepatitis C (CHC) is one of the commonest infectious diseases of the liver and may lead to cirrhosis or hepatocellular carcinoma. Combination therapy with pegylated interferon (PEG-IFN) and Ribavirin is the treatment of choice for CHC. Combination therapy is thought to act by means of antiviral mechanisms and immunomodulation. Thyroid dysfunction is the most common autoimmune adverse effect associated with combination therapy; hypothyroidism is more common than hyperthyroidism. Antithyroid antibodies and female sex have a predictive value in the development of interferon induced thyroid disease (IITD). Patients with CHC should be informed of the possibility of side effects on the thyroid gland. Screening for antithyroid antibodies and thyroid function tests should be performed in patients with CHC before the commencement of antiviral treatment, and during and after it. This article reviews different aspects of IITD, including its pathogenesis, clinical manifestations, association with treatment regimens and treatment response and the outcome of thyroid dysfunction.